首页> 美国卫生研究院文献>Frontiers in Endocrinology >Growth Hormone and Endometrial Receptivity
【2h】

Growth Hormone and Endometrial Receptivity

机译:生长激素和子宫内膜容受性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Administration of growth hormone (GH) during ovarian stimulation has shown beneficial effects on in vitro fertilization (IVF) outcomes. It is generally believed that this improvement is due to the stimulating effect of GH on oocyte quality. However, studies are emerging that show possible positive effect of GH administration on endometrial receptivity, thus suggesting an additional potential benefit at the level of the uterus, especially among women with recurrent implantation failure, thin endometrium, and older normal responders. This review summarizes recent data on GH co-treatment effects on endometrium and endometrial receptivity among infertile women undergoing IVF, and proposes possible mechanisms of GH actions in the endometrium.
机译:在卵巢刺激期间施用生长激素(GH)已显示出对体外受精(IVF)结果的有益作用。通常认为,这种改善是由于GH对卵母细胞质量的刺激作用。然而,正在出现的研究表明,GH给药对子宫内膜容受性可能具有积极作用,因此提示在子宫水平,特别是在复发性植入失败,子宫内膜稀薄和正常应答者较老的女性中,可能还有其他潜在益处。这篇综述总结了GH联合治疗对接受IVF的不育妇女子宫内膜和子宫内膜容受性影响的最新数据,并提出了GH在子宫内膜作用的可能机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号